Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435019
Status:
COMPLETED
Last Update Posted:
2017-03-10
First Post:
2007-02-13
Brief Title:
Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
An Efficacy and Safety Comparison of Insulin Detemir vs NPH Insulin in Children and Adolescents Diagnosed With Type 1 Diabetes
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in Europe
The aim of this research is to compare the efficacy and safety of treatment with NPH insulin and insulin detemir You will be treated with either insulin detemir or NPH insulin once or twice daily as basal insulin Additionally you will receive insulin aspart as bolus insulin
The aim of this research is to compare the efficacy and safety of treatment with NPH insulin and insulin detemir You will be treated with either insulin detemir or NPH insulin once or twice daily as basal insulin Additionally you will receive insulin aspart as bolus insulin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-000051-18 | EUDRACT_NUMBER | None | None |